Retractable Technologies (RVP) Cash from Investing Activities (2010 - 2026)
Retractable Technologies (RVP) reported Cash from Investing Activities of $1.7 million for Q1 2026, up 122.01% on a YoY basis from $762239.0 in Q1 2025, and up 1575.37% quarter-over-quarter from -$114698.0 in Q4 2025.
Retractable Technologies (RVP) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Retractable Technologies has reported Cash from Investing Activities for 17 years, with the latest figure at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 122.01% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (up 40.4% YoY), and the FY2025 full-year result was $6.0 million, up 63.51% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $1.7 million, up from -$114698.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $3.5 million in Q2 2025, with the low at -$17.6 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$1.8 million across 5 years, with a median of -$322324.0 in 2024.
- The largest YoY upside for Cash from Investing Activities was 1197.4% in 2025 against a maximum downside of 107.35% in 2025.
- Retractable Technologies' Cash from Investing Activities stood at -$3.1 million in 2022, then soared by 88.6% to -$347758.0 in 2023, then soared by 548.55% to $1.6 million in 2024, then plunged by 107.35% to -$114698.0 in 2025, then jumped by 1575.37% to $1.7 million in 2026.
- The last three Cash from Investing Activities figures came in at $1.7 million (Q1 2026), -$114698.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Retractable Technologies | 19.78 Mn | -15.84 Mn | -838,408.00 | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | -114,698.00 |
| Dec 31, 2025 | -114,698.00 |
| Sep 30, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Mar 31, 2025 | 762,239.00 |
| Mar 31, 2025 | 762,239.00 |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | -322,324.00 |
| Jun 30, 2024 | -322,324.00 |
| Mar 31, 2024 | -502,722.00 |
| Mar 31, 2024 | -502,722.00 |
| Dec 31, 2023 | -347,758.00 |
| Dec 31, 2023 | -347,758.00 |